STOCK TITAN

Vanguard lists 0% stake in Lam Research (NASDAQ: LRCX) after realignment

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Lam Research Corp: The Vanguard Group filed Amendment No. 14 to a Schedule 13G/A reporting that, after an internal realignment, it beneficially owns 0 shares of common stock, representing 0% of the class. The filing states certain Vanguard subsidiaries will report ownership separately in reliance on SEC Release No. 34-39538.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregated holdings; reported zero beneficial ownership in Lam Research.

The amendment states The Vanguard Group underwent an internal realignment and that certain subsidiaries will report ownership separately pursuant to SEC Release No. 34-39538. The filing lists 0 shares and 0% ownership for The Vanguard Group itself.

This is an administrative reporting change; cash-flow treatment and subsidiary positions are not described in this excerpt.

Schedule 13G/A amendment documents a reporting structure change, not a market transaction.

The form clarifies that after the internal reorganization, The Vanguard Group, Inc. no longer is deemed to beneficially own the securities held by those subsidiaries. The signature block shows the filing was signed on 03/27/2026 by the Head of Global Fund Administration.

Investors should note this is a disclosure update; the excerpt does not quantify subsidiary holdings or timing of their separate filings.






512807306

(CUSIP Number)
03/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What did The Vanguard Group report for Lam Research (LRCX)?

The Vanguard Group reported 0 shares beneficially owned, representing 0% of Lam Research common stock. The amendment states certain subsidiaries will report ownership separately pursuant to SEC Release No. 34-39538 after an internal realignment.

Does this filing show Vanguard sold Lam Research shares?

No; the amendment documents an internal realignment and separate reporting by subsidiaries. The filing lists 0 shares for The Vanguard Group itself and does not state any sale or market transactions in this excerpt.

Will subsidiary holdings be disclosed separately for LRCX?

Yes; the filing states that certain Vanguard subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538. The excerpt does not include those subsidiaries’ specific holdings or filing dates.

What is the significance of SEC Release No. 34-39538 in this filing?

The release permits disaggregated reporting by subsidiaries after internal reorganization. The amendment cites it as the basis for subsidiaries to report separately and for The Vanguard Group to state it no longer is deemed to beneficially own those securities.

Who signed the Schedule 13G/A amendment and when?

The form was signed by Ashley Grim, Head of Global Fund Administration, with a signature date of 03/27/2026. The filing includes The Vanguard Group’s address at 100 Vanguard Blvd., Malvern, PA.
Lam Research

NASDAQ:LRCX

View LRCX Stock Overview

LRCX Rankings

LRCX Latest News

LRCX Latest SEC Filings

LRCX Stock Data

264.26B
1.24B
Semiconductor Equipment & Materials
Special Industry Machinery, Nec
Link
United States
FREMONT